BETA vs BMY · rev $8.9M vs P/E 17, rev $48.19B
Beta Technologies, Inc. (BETA) versus Bristol-Myers Squibb Company (BMY) — a side-by-side from cached financials, not a winner call.
Beta Technologies, Inc. (BETA) is a aerospace & defense company listed on NYSE.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Latest reported BETA revenue for 2025-09-30 was $8.9M. Net income was -$437.2M. Revenue was up 190.9% from 2024-09-30 to 2025-09-30. BETA currently screens at market cap $3.72B.
Latest reported BMY revenue for 2025-12-31 was $48.19B. Net income was $7.05B. Revenue was down 0.2% from 2024-12-31 to 2025-12-31. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
BETA currently screens at market cap $3.72B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Not investment advice. Open the BETA and BMY stock pages for the full models.
Not investment advice.